Galderma 同意以约 15 亿美元收购 ZO Skin Health

Popular Searches

Please try another search

Top Brokers

Image 1: Plus500

Plus500

4.9

★★★★★

Open Account

Read Review

eToro

4.8

★★★★★

Open Account

Read Review

Tools

Calendars * Economic Calendar * Holiday Calendar * Earnings Calendar * Dividend Calendar * Splits Calendar * IPO Calendar * Futures Expiry Calendar

Investment Tools

*   [Stock Screener](https://www.investing.com/stock-screener)
*   [Fed Rate Monitor Tool](https://www.investing.com/central-banks/fed-rate-monitor)
*   [Currency Converter](https://www.investing.com/currency-converter/)
*   [Fibonacci Calculator](https://www.investing.com/tools/fibonacci-calculator)

Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say

By Image 3: Reuters

Stock Markets

Published Oct 13, 2026, 07:18 PM

Updated Oct 13, 2026, 07:24 PM

Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say

View all comments (0)0

Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say

View all comments (0)0

Image 4: © Reuters.

In this article:

OREP+1.07%

BX-4.18%

GALD-0.48%

By Abigail Summerville

NEW YORK, Oct 13 (Reuters) - Swiss skincare conglomerate Galderma has agreed to buy medical-grade skincare company ZO Skin Health for around $1.5 billion, according to two people familiar with the matter.

A deal could be announced in the coming days, the people said.

ZO and Galderma, which were contacted outside regular business hours, did not immediately respond to requests for comment.

ZO’s owner, investment firm Blackstone, was exploring a sale of the company with investment banks Citigroup and Raymond James, Reuters reported last month. Blackstone declined to comment on Tuesday.

The move by dermatology company Galderma, in which beauty giant L’Oréal owns a 20% stake, will expand its presence in the US market. In August, the company opened a US and Latin America headquarters in Miami.

Established in 1981, Galderma also owns skincare brands Cetaphil and Alastin Skincare,Differin Epiduo acne gel,injectable neurotoxin Dysport, and dermal filler brand Restylane.

Many strategic buyers are prioritizing clinically backed, physician-distributed skincare brands like ZO because of their efficacy ⁠and steadier demand versus over-the-counter products.

Dermatologist ⁠Zein Obagi founded ZO in 2007. ZO sells skincare products including cleansers, serums, exfoliators and toners that are distributed by ⁠physicians and skincare professionals.

Blackstone acquired ZO through its tactical opportunities fund in 2020.

OREP+1.07%BX-4.18%GALD-0.48%

L'Oreal

Analyze OREP

Included in our AI-picked strategies

Review strategies

387.15

▲+4.10(+1.07%)

Closed·11:35:59·EUR

Max

In this article

OREP+1.07%BX-4.18%GALD-0.48%

Trade

Analyze OREP

Trade

Is OREP a bargain right now?

Our Fair Value model runs 17 proven valuation methods on OREP and returns one number: what the stock is worth today, and how far the current price sits from it.

Same calculation on thousands of other stocks — so you can see instantly whether OREP is the best value on the table, or whether something cheaper is hiding in plain sight.

Flash Sale - 55% Off InvestingPro

Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say

View all comments (0)0

Latest comments

Post

Comment Guidelines

Loading next article…

Trade With A Regulated Broker

Indices Commodities Bonds Stocks

Max

US 30

51,656.60

-14.4

-0.03%

US 500

7,805.00

-0.6

-0.01%

Dow Jones

51,670.10

-180.45

-0.35%

S&P 500

7,805.64

-1.60

-0.02%

Nasdaq

27,204.38

-41.52

-0.15%

S&P 500 VIX

15.27

+0.06

+0.39%

Dollar Index

101.989

+0.009

+0.01%

Crude Oil WTI Futures

94.65

+0.51

+0.54%

Brent Oil Futures

106.29

-0.36

-0.34%

Natural Gas Futures

3.319

+0.039

+1.19%

Gold Futures

4,178.70

+1.40

+0.03%

Silver Futures

59.165

-0.365

-0.61%

Copper Futures

6.7203

-0.0097

-0.14%

US Soybeans Futures

1,282.25

-1.50

-0.12%

U.S. 10Y

5.215

-0.002

-0.04%

U.S. 30Y

5.565

+0.002

+0.04%

U.S. 5Y

5.009

+0.002

+0.04%

U.S. 3M

4.164

0.000

0.00%

US 10Y T-Note Futures

104.73

0.00

0.00%

Euro Bund Futures

121.06

+0.10

+0.08%

10-2 Yield Spread

31.32

+4.15

+15.27%

AAPL

341.27

+0.30

+0.09%

NVDA

228.51

+2.19

+0.97%

GOOGL

353.78

+1.06

+0.30%

TSLA

375.23

-2.80

-0.74%

AMZN

258.58

-0.95

-0.37%

NFLX

70.46

-0.15

-0.21%

Name	Last	Chg. %	Vol.
CDW	151.97	+5.71%	2.42M
VLO	456.37	+4.67%	2.16M
CHTR	106.95	+4.36%	2.88M
ORCL	143.20	+4.23%	22.40M
PSX	292.73	+4.00%	1.71M
MPC	476.98	+3.96%	1.30M
FSLR	186.60	+3.83%	2.27M

Name	Last	Chg. %	Vol.
AMAT	464.24	-6.69%	10.46M
JNJ	248.61	-5.73%	13.51M
C	124.53	-5.60%	18.15M
DPZ	296.10	-4.76%	2.01M
KKR	87.16	-4.75%	7.26M
VRTX	485.22	-4.30%	1.06M
SPCX	156.54	-4.21%	66.42M

Trending Stocks

Name	Last	Chg. %	Vol.
MU	952.95	-3.65%	26.50M
SNDK	1,482.33	-0.34%	8.06M
NVDA	228.51	+0.97%	65.47M
JPM	331.43	-0.86%	11.44M
SPCX	156.54	-4.21%	66.42M

ProPicks AI

AI-powered stock picks with a proven track record to beat the S&P 500.

Tech Titans

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Top Value Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best of Buffett

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Energy Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Financial Fortresses

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Quality Compounders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Small-Cap Sprinters

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Healthcare Heroes

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Beat the S&P 500

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Dominate the Dow

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mid-Cap Movers

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mexican Stock Exchange Leaders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best Brazilian Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Italian Market Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Alpha Germany Select

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Comments

Post

Comment Guidelines

Calendars

Economic Calendar Earnings Calendar Holiday Calendar

US Economy

Fed Rate Monitor Tool US Treasury Yield Curve

More Tools

Stock Screener Currency Converter

Markets Ask WarrenAI Stocks Picked by AI Watchlist Alerts Top Brokers Breaking News Tools

Install Our App Scan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.Fusion Mediaand any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.